Silo Pharma, Inc. — Director's Dealing 2022

Jan 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Silo Pharma, Inc. (SILO)
CIK: 0001514183
Period of Report: 2021-12-29

Reporting Person: Linsley Wayne (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-29	Non-Qualified Stock Option	$0.1460	A	171233	Acquired	2026-12-29	Common Stock (171233)	Direct
2021-12-29	Non-Qualified Stock Option	$0.1460	A	171233	Acquired	2026-12-29	Common Stock (171233)	Direct

Footnotes

F1: Vests over the course of one year from grant with 100% vesting a year from the date of grant.

F2: The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan.